You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 6306 results
  1. mSense: Mobile & Wearable Sensing at scale

    SBC: THINKSENSE INC.            Topic: HR0011SB2023405

    The main objective of this effort is to provide a secure and lightweight framework for real-time analysis of sensory data from wearables. Our goal is to continuously monitor warfighter health and readiness at the edge in real-time while consuming less than 5% of the wearable battery over 10 days. Our system enables the provisioning and instantiation of different edge-deployed algorithms to address ...

    SBIR Phase II 2023 Department of DefenseDefense Advanced Research Projects Agency
  2. Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain

    SBC: RIVANNA MEDICAL, INC.            Topic: NIAMS

    PROJECT SUMMARY/ABSTRACT For the rt330,000 Americans that are hospitalized for hip fractures yearly, rapid treatment of pain and surgical intervention is critical to recover mobility and reduce the risk of death. Parenteral opioids are the standard of care to manage acute hip fracture pain but increase the risk of adverse events and outcomes, including delirium and recurrent opioid use. Ultrasound ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy

    SBC: IllExcor Therapeutics LLC            Topic: NHLBI

    Sickle Cell Disease (SCD) affects ~100,000 individuals in the US and millions more worldwide. The disease causes a range of adverse pathophysiological effects resulting in painful crises, organ failure, and eventually, premature death. Our scientists spearheaded the development of a novel class of oral anti-sickling drugs based on natural aromatic aldehydes, like vanillin from vanilla extract. Thi ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Workable Hierarchical Impersonation using Reinforcement Learning (WHIRL)

    SBC: Cynnovative, LLC            Topic: HR0011SB2023402

    Workable Hierarchical Impersonation using Reinforcement Learning (WHIRL) will generate realistic synthetic data without artifacts at scale by utilizing hierarchical reinforcement learning and a hypervisor to allow for “off-box” execution of long-term goals, mid-term tasks, passed through a shim to a hypervisor that will execute them on the intended host. Team Cynnovative will use hierarchical ...

    SBIR Phase II 2023 Department of DefenseDefense Advanced Research Projects Agency
  5. FA8307-23-R-B014- VivSoft STRATFI Phase II

    SBC: VIVSOFT TECHNOLOGIES LLC            Topic: AF193CSO1

    VivSoft is providing Natural Language Processing (NLP); Data Engineering; R2D2; and a Unified Platform (UPv1) support to create an environment which will provide secure collaboration in the development of MLOps capabilities for the LevelUP program.  To su

    SBIR Phase II 2023 Department of DefenseAir Force
  6. Zeno Power Systems Strategic Financing Increase (STRATFI) Proposal

    SBC: ZENO POWER SYSTEMS, INC.            Topic: AF192D001

    At Zeno, we’re developing an next-generation radioisotope power system (RPS) that operates by converting the heat from decaying radioisotopes directly into electricity – providing always-on, resilient power in the W-kW range for years at a time. NASA and the U.S. Department of Defense have historically used RPSs, but the cost or weight of these systems limited their broader usability. Zeno's ...

    SBIR Phase II 2022 Department of DefenseAir Force
  7. Replicants: Synthetic User Personas for Cyber Security Experimentation

    SBC: Punch Cyber Corp.            Topic: HR0011SB2023402

    ???????PUNCH proposes Replicant, a five-component framework that provides: state-awareness, actuation, behavior modeling, data labeling, and orchestration / management of synthetic users without leaving traces of Replicant itself. Replicant’s Perception, Driver, and Persona components are jump started by our work on the DARPA CHASE program where PUNCH: (1) created (in collaboration with FiveDire ...

    SBIR Phase II 2023 Department of DefenseDefense Advanced Research Projects Agency
  8. eSTOL Aircraft Rapid Development, Prototyping, Test, and Evaluation

    SBC: ELECTRA.AERO INC.            Topic: AF203DCSO1

    Driven by the latest strategy directives – including the SECAF’s Operational Imperatives, USAF Chief of Staff’s Agile Combat Employment (ACE) doctrine, and USAF Operational Energy goals – the USAF has clearly articulated requirements for tactical logistic

    SBIR Phase II 2023 Department of DefenseAir Force
  9. SUPER Synthetic User Persona EmulatoR

    SBC: Five Directions, Inc            Topic: HR0011SB2023402

    Five Directions is pleased to propose to the SUP direct to Phase II program an end-to-end synthetic data generation and labeling framework featuring our user emulation and data labeling prototypes. The Synthetic User Persona EmulatoR (SUPER) will be researched and developed by a team of security experts with experience in endpoint and network telemetry systems and traffic generation, and a passion ...

    SBIR Phase II 2023 Department of DefenseDefense Advanced Research Projects Agency
  10. Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier

    SBC: IllExcor Therapeutics LLC            Topic: NHLBI

    Acute respiratory distress syndrome (ARDS) is a life-threatening condition featuring acute onset of non- cardiogenic respiratory failure and hypoxemia. Consequently, patients with ARDS have severe hypoxemia due to a significant impairment of gas exchange, and the goal of supportive therapy is to prevent critical tissue hypoxia, which can cause acute cardiac arrest and death or have long-term neuro ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government